Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block

Europace

Volumn 9, Issue 10, 2007, Pages 869-874

  Shimano, Masayuki ^a,b   Tsuji, Yukiomi ^c   Yoshida, Yukihiko ^b   Inden, Yasuya ^a   Tsuboi, Naoya ^b   Itoh, Teruo ^b   Suzuki, Hirohiko ^b   Muramatsu, Takashi ^b   Okada, Taro ^b   Harata, Shuji ^b   Yamada, Takumi ^d   Hirayama, Haruo ^b   Nattel, Stanley ^e,f   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d University of Alabama at Birmingham   (United States)

^e MONTREAL HEART INSTITUTE   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Complete AV block; Heart failure; Pacing; Resynchronization

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; HEART; HEART MUSCLE CONDUCTION SYSTEM; HEART PACING; HEART VENTRICLE; HEMODYNAMICS; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; REPRODUCIBILITY; TIME;

AGED; AGED, 80 AND OVER; ATRIOVENTRICULAR BLOCK; CARDIAC PACING, ARTIFICIAL; HEART; HEART CONDUCTION SYSTEM; HEART FAILURE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 42449089080     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum119     Document Type: Article

References (23)

1. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-62.
2. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7.
3. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002;288:3115-23.
4. Sweeney MO, Prinzen FW. A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 2006;47:282-8.
5. Thambo JB, Bordachar P, Garrigue S, Lafitte S, Sanders P, Reuter S, et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation 2004;110:3766-72.
6. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145- 55.
7. Tse HF, Lau CP. Selection of permanent ventricular pacing site: how far should we go? J Am Coll Cardiol 2006;48:1649-51.
8. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
9. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873- 80.
10. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
11. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
12. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
13. Erol-Yilmaz A, Tukkie R, Schrama TA, Romkes HJ, Wilde AA. Reversed remodelling of dilated left sided cardiomyopathy after upgrading from VVIR to VVIR biventricular pacing. Europace 2002;4:445-9.
14. Baker CM, Christopher TJ, Smith PF, Langberg JJ, Delurgio DB, Leon AR. Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: feasibility, safety, and early results in 60 consecutive patients. Pacing Clin Electrophysiol 2002;25:1166-71.
15. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258- 63.
16. Witte KK, Pipes RR, Nanthakumar K, Parker JD. Biventricular pacemaker upgrade in previously paced heart failure patients-improvements in ventricular dyssynchrony. J Card Fail 2006;12:199-204.
17. Valls-Bertault V, Fatemi M, Gilard M, Pennec PY, Etienne Y, Blanc JJ. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004;6:438-43.
18. Shimano M, Inden Y, Yoshida Y, Tsuji Y, Tsuboi N, Okada T, et al. Does RV lead positioning provide additional benefit to cardiac resynchronization therapy in patients with advanced heart failure? Pacing Clin Electrophysiol 2006;29:1069-74.
19. Spragg DD, Kass DA. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis 2006;49:26-41.
20. Tantengco MV, Thomas RL, Karpawich PP. Left ventricular dysfunction after long-term right ventricular apical pacing in the young. J Am Coll Cardiol 2001;37:2093-100.
21. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac function in pacemaker patients upgraded to biventricular devices. J Cardiovasc Electrophysiol 2004;15:1284-9.
22. Heymans S, Lupu F, Terclavers S, Vanwetswinkel B, Herbert JM, Baker A, et al. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Am J Pathol 2005;166:15-25.
23. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006;92:282-8.